BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calhan T, Senateş E, Cebeci E, Zuhur SS, Ozbakır F, Görpe U. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism. Endocrine 2010;38:199-205. [PMID: 21046481 DOI: 10.1007/s12020-010-9373-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Khan NA, Singh M. Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves’ disease independent of anti-thyroid drug therapy. Modern Rheumatology 2014;22:778-82. [DOI: 10.3109/s10165-011-0570-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Coster A, Dargent J, de Visscher N, Levecque P, Roquet-gravy P. Pyoderma gangrenosum avec anticorps anti-cytoplasme des neutrophiles de type anti-protéinase 3 (PR3-ANCA) induits par le propylthiouracile. Annales de Dermatologie et de Vénéréologie 2017;144:368-73. [DOI: 10.1016/j.annder.2017.01.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Xu Y, Xu F, Li W, Li M, Dong S, Zhang Y, Norman GL, Zhao Q, Liu L. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 2020;55:806-13. [PMID: 32568566 DOI: 10.1080/00365521.2020.1781926] [Reference Citation Analysis]
4 Hou X, Liu J, Wang T, Zhou J, Cui L. The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies. J Clin Lab Anal 2021;35:e23615. [PMID: 33034910 DOI: 10.1002/jcla.23615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]